Jul 27 (Reuters)-
Kainos Laboratories Inc
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Jun 30, 2020 Jun 30, 2019 Mar 31, 2021
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 989 mln 1.09 4.50
(-9.4 pct) (-7.4 pct) (-2.4 pct)
Operating 161 mln 87 mln 450 mln
(+84.3 pct) (-55.8 pct) (-26.1 pct)
Recurring 166 mln 89 mln 450 mln
(+86.2 pct) (-55.6 pct) (-27.0 pct)
Net 124 mln 43 mln 300 mln
(+183.0 pct) (-68.1 pct) (-24.7 pct)
EPS 29.75 yen 11.18 yen 71.74 yen
Ann Div 15.00 yen 15.00 yen
-Q2 div NIL NIL
-Q4 div 15.00 yen 15.00 yen
NOTE - Kainos Laboratories Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4556.T